US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

55.75

+1.622.99%

Volume:17.96K

Turnover:1.00M

Market Cap:52.96M

PE:- -

High:55.96

Open:55.45

Low:55.45

Close:54.13

52wk High:56.18

52wk Low:22.43

Shares:950.00K

Float Shares:950.00K

Volume Ratio:1.40

T/O Rate:1.89%

Dividend:0.66

Dividend Rate:1.17%

ROE:--

ROA:--

PB:1.20

PE(LYR):- -

Loading ...

Overview Company News Filings

Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market

Romesh Ranganathan makes it hard to defend the BBC

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update

10 Friday AM Reads

The Big Picture

UK Government Enacts Legislation to Nationalize British Steel, Controlled by China's Jingye Group; Chinese Ministry of Commerce Vows Strong Measures to Protect Chinese Firms

Lilly Quietly Expands Its Obesity Pipeline With New Early-Stage LY4174794 Trial

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats

England semi pulls in 24m on BBC but falls short of Euros final

Tracking the Former President's Recent Activities and Statements

U.S. Government Contemplating Involvement in Trump's Defamation Lawsuit Against BBC

Kairos Pharma announces interim safety data from Phase 1 trial of ENV-105

Veradermics announces results from Phase 2 trial of VDPHL01

AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors

Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4

Praxis Precision initiated with a Buy at Goldman Sachs

IN8bio therapy doubles progression free survival in brain cancer trial

Racura to Present RC220 Cardio-Oncology Phase 1 Data at 2026 Global Summit

Satellos Bioscience Posts Encouraging Six-Month TRAILHEAD Data in Adult DMD Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BBC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":55.75,"timestamp":1787679184147,"preClose":54.1302,"halted":0,"volume":17962,"delay":0,"changeRate":0.02992414585573299,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Trading","change":1.6198,"latestTime":"08-25 13:33:15 EDT","open":55.4522,"high":55.96,"low":55.4522,"amount":1002313.296712,"amplitude":0.009381,"askPrice":55.94,"askSize":100,"bidPrice":55.25,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":54.1302,"sharesOutstanding":900004,"nav":54.405,"aum":51684743.81,"dividendRate":0.011749,"bidAskSpread":0.001944,"postHourTrading":{"tag":"盘后","latestPrice":54.37,"preClose":54.1302,"latestTime":"19:41 EDT","volume":71,"amount":3850.4118,"timestamp":1787614899758,"change":0.2398,"changeRate":0.00443,"amplitude":0},"volumeRatio":1.399111,"impliedVol":0.3453,"impliedVolPercentile":0.6574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.399111,"shares":950000,"dividePrice":0.655,"high":55.96,"amplitude":0.009381,"preClose":54.1302,"low":55.4522,"week52Low":22.43,"pbRate":"1.20","week52High":56.18,"institutionHeld":0,"latestPrice":55.75,"committee":0.666667,"eps":0,"divideRate":0.011749,"volume":17962,"delay":0,"ttmEps":0,"open":55.4522,"prevYearClose":38.56,"prevWeekClose":54.4632,"prevMonthClose":48.7362,"prevQuarterClose":52.6861,"fiveDayClose":53.81,"twentyDayClose":48.8478,"sixtyDayClose":44.5673},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653171362","title":"Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653171362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653171362?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:31","pubTimestamp":1784565094,"startTime":"0","endTime":"0","summary":"Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has launched a Phase 3 trial testing petosemtamab plus chemotherap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653131217","title":"Romesh Ranganathan makes it hard to defend the BBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2653131217","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653131217?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:17","pubTimestamp":1784564255,"startTime":"0","endTime":"0","summary":"The nearly four minute political broadcast on the nature of broadcast asks us to consider not what our BBC can do for us, but what we can do for our BBC. Romesh is whisked through a dizzying sweep of iconic TV locations – the Queen Vic, Graham Norton’s studio, the Strictly ballroom – as he repeats the central question in the dull, rhythmic style of a mid-ranking Labour minister.There are great cases to be made for the BBC. It projects British strength, creates tangible cultural moments, and knits together a framework of shared reality. But its own propaganda seems to miss all of this, and instead pummels the viewer with the grinning faces of its best-paid stars.Strictly and Traitors aside, not many BBC properties pull in viewers by the tens-of-millions anymore. As Romesh quips, “there are shows I wouldn’t dare to belittle,” he is duly chased by Daleks – part of the Doctor Who brand recently run into the ground by poorly-judged American financing and audience disinterest. So, it made se","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/romesh.ranganathan.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/romesh.ranganathan.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bbc-licence-fee-romesh-ranganathan-world-cup/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bbc-licence-fee-romesh-ranganathan-world-cup/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652840282","title":"GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2652840282","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652840282?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:32","pubTimestamp":1784305947,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The ALANIS study from GlaxoSmithKline (GSK) is a Phase 2 trial testing ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","BK4588","PSIL","GSKH","IE00B19Z6F94.USD","LU1829250122.USD","GSK.UK","IE0034390439.USD","BK4104","LU1169589451.USD","BK4007","LU1169590202.USD","BBC","BK4585","AL","BK4572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284010","title":"Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284010?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305889,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. Mirum Pharmaceuticals, Inc. is running a Phase 1 trial called “A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirum-advances-new-drug-candidate-with-fresh-phase-1-study-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirum-advances-new-drug-candidate-with-fresh-phase-1-study-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284217","title":"10 Friday AM Reads","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284217","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284217?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:30","pubTimestamp":1784284240,"startTime":"0","endTime":"0","summary":"Wall Street Traders Are Having Their Best Year Ever: JPMorgan, Goldman and other big banks are raking in trading revenue this year as “the market is clearly extremely risk-on.” . From spicy claypot chicken to ‘digitally enabled technology infrastructure player’: Back in 2017, a tiny US-listed drinks company called Long Island Iced Tea suddenly announced that it would henceforth be known as Long Blockchain Company and promptly jumped as much as 500 per cent. It ended pretty much as you’d expect. Even the Nasdaq was shamed into taking action, delisting the company from its exchange. The SEC then got involved, and today the company is no more. Did doubt for even a minute t hat this would end in any other way?!","market":"nz","thumbnail":"https://ritholtz.com/wp-content/uploads/2030/07/retail.png","type":0,"news_type":0,"thumbnails":["https://ritholtz.com/wp-content/uploads/2030/07/retail.png"],"rights":{"source":"ritholtz_highlight","url":"https://ritholtz.com/2026/07/10-friday-am-reads-507/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2026/07/10-friday-am-reads-507/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["IE00BMQBXF63.USD","BBC","BK4144","AM","IE00BZ18W340.USD","IE00BZ18W456.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172393686","title":"UK Government Enacts Legislation to Nationalize British Steel, Controlled by China's Jingye Group; Chinese Ministry of Commerce Vows Strong Measures to Protect Chinese Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1172393686","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172393686?lang=en_us&edition=fundamental","pubTime":"2026-07-17 13:52","pubTimestamp":1784267563,"startTime":"0","endTime":"0","summary":"The Chinese Ministry of Commerce has responded to media inquiries regarding the UK government's move to nationalize British Steel.In response to a question about the UK government's announcement on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425762","title":"Lilly Quietly Expands Its Obesity Pipeline With New Early-Stage LY4174794 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425762","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425762?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:32","pubTimestamp":1784219530,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is running a Phase 1 trial called “A Phase ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-quietly-expands-its-obesity-pipeline-with-new-early-stage-ly4174794-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-quietly-expands-its-obesity-pipeline-with-new-early-stage-ly4174794-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652042578","title":"GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652042578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652042578?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219518,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 1 trial to test an infant pneumoco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BK4588","GSKH","GSK","GSK.UK","BK4007","LU1829250122.USD","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652142579","title":"Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats","url":"https://stock-news.laohu8.com/highlight/detail?id=2652142579","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652142579?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:30","pubTimestamp":1784219437,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 1 trial that tests how its obesity d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-obesity-pipeline-with-fresh-data-on-amg-133-injection-formats?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-obesity-pipeline-with-fresh-data-on-amg-133-injection-formats?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4135","IE0002141913.USD","LU1023059063.AUD","LU1571399168.USD","PBE","IE00BGHQF748.EUR","IE00B4R5TH58.HKD","LU2242652126.USD","BK4585","IE00B3QW5Z07.USD","BK4581","PJP","IBB","LU2242646821.SGD","BK4534","BIB","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1983299246.USD","LU0122379950.USD","BBH","IE00BJT1NW94.SGD","IBBQ","BK4566","LU0289739699.SGD","LU1061106388.HKD","LU0868494617.USD","LU0320765992.SGD","IE00B64PRP62.GBP","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","AMGN","BK4588","IE00B2B36J28.USD","BBC","BK4139","IE00BJJMRZ35.SGD","LU2112291526.USD","BK4505","AMG","BK4533","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441565","title":"England semi pulls in 24m on BBC but falls short of Euros final","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441565","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651441565?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:19","pubTimestamp":1784200790,"startTime":"0","endTime":"0","summary":"BBC coverage of England getting dumped out of the World Cup broke 2026 records BBC coverage of England getting dumped out of the World Cup broke 2026 records but fell short of other football matches in historical rankings.Around 24m watched Argentina’s late 2-1 win in Atlanta, making the match the most-watched live television moment of the year.The broadcast averaged 22.1m viewers on the BBC with the channel’s social media platforms attracting 75m video views on Wednesday.But the semi-final audience fell short of other major sporting moments. Its average of 22.1m falls short of the 2012 summer Olympic Games closing ceremony – which was shown on the BBC – as well as the 1970 FA Cup final replay between Chelsea and Leeds, the 2020 European final between Italy and England; and the 1966 World Cup final against West Germany.Both the BBC and ITV will broadcast the final between Argentina and Spain on Sunday.","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/GettyImages-2199824975-e1784200616979.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/GettyImages-2199824975-e1784200616979.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/england-semi-pulls-in-24m-on-bbc-but-falls-short-of-euros-final/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/england-semi-pulls-in-24m-on-bbc-but-falls-short-of-euros-final/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193584630","title":"Tracking the Former President's Recent Activities and Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=1193584630","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193584630?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199656,"startTime":"0","endTime":"0","summary":"Former US President Donald Trump has been active on multiple fronts over the past day, making statements on economic policy, national security, and international relations.He commented on inflation...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SINA","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112077647","title":"U.S. Government Contemplating Involvement in Trump's Defamation Lawsuit Against BBC","url":"https://stock-news.laohu8.com/highlight/detail?id=1112077647","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112077647?lang=en_us&edition=fundamental","pubTime":"2026-07-16 14:31","pubTimestamp":1784183474,"startTime":"0","endTime":"0","summary":"The U.S. government is considering a move to intervene in the defamation lawsuit filed by former President Donald Trump against the British Broadcasting Corporation, a development that could...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463448","title":"Kairos Pharma announces interim safety data from Phase 1 trial of ENV-105","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463448?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:35","pubTimestamp":1784118922,"startTime":"0","endTime":"0","summary":"Kairos Pharma (KAPA) announced interim safety data from its ongoing Phase 1 clinical trial evaluating ENV-105 in combination with osimertinib in pa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-announces-interim-safety-data-from-phase-1-trial-of-env-105-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-announces-interim-safety-data-from-phase-1-trial-of-env-105-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4139","KAIR","BBC","HYLG","MEDX","GDOC","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745716","title":"Veradermics announces results from Phase 2 trial of VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651745716?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:10","pubTimestamp":1784113852,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) announced positive topline results from its open-label Phase 2 clinical trial evaluating VDPHL01, a proprietary extended-release...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-announces-results-from-phase-2-trial-of-vdphl01-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-announces-results-from-phase-2-trial-of-vdphl01-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","GDOC","BK4007","MEDX","BBC","HYLG","IDNA","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651432941","title":"AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651432941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651432941?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:30","pubTimestamp":1783960212,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s latest update covers a Phase 1 trial titled “An Open-l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd5004-combo-data-with-diabetes-drugs-offering-subtle-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd5004-combo-data-with-diabetes-drugs-offering-subtle-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","BK4211","BBC","LU2462157665.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU0432979614.USD","LU1267930573.SGD","LU2456880835.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4007","AZN","LU2236285917.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","ISBC","AZNH","BK4588","LU2089984988.USD","BK4568","LU0320765992.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111408","title":"Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111408?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:40","pubTimestamp":1783946412,"startTime":"0","endTime":"0","summary":"Based on recent positive 12-week data from Part D of the CIRRUS-HCM Phase 2 trial of EDG-7500, which included safety, echocardiographic, biomarker,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-expects-to-initiate-phase-3-trial-of-edg-7500-in-q4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-expects-to-initiate-phase-3-trial-of-edg-7500-in-q4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","EWTX","BBC","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190997","title":"Praxis Precision initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190997?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:25","pubTimestamp":1783934704,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Praxis Precision (PRAX) with a Buy rating and $447 price target Praxis is a clinical-stage biotech company with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LU2237443465.HKD","BK4533","LU0048573561.USD","IE0002141913.USD","LU0345770993.USD","LU1868836591.USD","LU0106831901.USD","IE00BJJMRZ35.SGD","BBC","LU0742534661.SGD","LU2237443549.SGD","LU0889565916.HKD","LU2750360641.GBP","IBRN","LU1894683348.USD","LU2237438978.USD","LU2471134796.USD","LU2750360997.AUD","LU0942090050.USD","LU0061475181.USD","IE0004086264.USD","IE0004091025.USD","LU0868494708.USD","GSX","LU1804176565.USD","IE0034235188.USD","IE00B2B36J28.USD","LU2237443622.USD","LU2471134523.USD","LU2237443382.USD","BK4552","IE00BFTCPJ56.SGD","BK4516","BK4504","IE0009355771.USD","LU1868836914.USD","LU1894683264.USD","BK4588","IE00B4R5TH58.HKD","LU1868837136.USD","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU1791807156.HKD","BK4127","BK4139","PRAX","LU0345770308.USD","IE00B19Z3B42.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650376927","title":"IN8bio therapy doubles progression free survival in brain cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2650376927","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650376927?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:35","pubTimestamp":1783604120,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) announced the publication of peer-reviewed clinical data from its Phase 1 trial of INB-200 in The Journal of Clinical Oncology. “Thes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-therapy-doubles-progression-free-survival-in-brain-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-therapy-doubles-progression-free-survival-in-brain-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650912901","title":"Racura to Present RC220 Cardio-Oncology Phase 1 Data at 2026 Global Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2650912901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650912901?lang=en_us&edition=fundamental","pubTime":"2026-07-09 08:57","pubTimestamp":1783558651,"startTime":"0","endTime":"0","summary":"Race Oncology Ltd. ( ($AU:RAC) ) has provided an announcement. Racura Oncology will present new clinical data from its ongoing CPACS Phase 1 trial ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/racura-to-present-rc220-cardio-oncology-phase-1-data-at-2026-global-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/racura-to-present-rc220-cardio-oncology-phase-1-data-at-2026-global-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SMMF","BBC","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999887","title":"Satellos Bioscience Posts Encouraging Six-Month TRAILHEAD Data in Adult DMD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999887?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:57","pubTimestamp":1783508255,"startTime":"0","endTime":"0","summary":"The latest update is out from Satellos Bioscience ( ($TSE:MSCL) ). Satellos Bioscience Inc., a clinical-stage biotechnology company developing the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/satellos-bioscience-posts-encouraging-six-month-trailhead-data-in-adult-dmd-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/satellos-bioscience-posts-encouraging-six-month-trailhead-data-in-adult-dmd-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","JDOC","BBP","FWD","SYNB","AGNG","RSPH","BK4585","BK4588","XT","DARP","FHLC","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":118,"code":"91000000","status":"200"}]}}